William D. Rees
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Dysregulated Immunity to Clostridioides difficile in IBD Patients Without a History of Recognized Infection.
Journal: Inflammatory bowel diseases
Published: May 16, 2023
Inhibition of glycogen synthase kinase-3-beta (GSK3β) blocks nucleocapsid phosphorylation and SARS-CoV-2 replication.
Journal: Molecular biomedicine
Published: September 23, 2022
Flagellin-specific human CAR Tregs for immune regulation in IBD.
Journal: Journal of autoimmunity
Published: September 10, 2022
A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic.
Journal: Nature
Published: May 14, 2021
A novel highly potent inhibitor of TMPRSS2-like proteases blocks SARS-CoV-2 variants of concern and is broadly protective against infection and mortality in mice.
Journal: bioRxiv : the preprint server for biology
Published: May 11, 2021
Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection Enhances Adaptive Immunity to C difficile Toxin B.
Journal: Gastroenterology
Published: November 13, 2020
Regenerative Intestinal Stem Cells Induced by Acute and Chronic Injury: The Saving Grace of the Epithelium?
Journal: Frontiers in cell and developmental biology
Published: July 16, 2020
Enteroids Derived From Inflammatory Bowel Disease Patients Display Dysregulated Endoplasmic Reticulum Stress Pathways, Leading to Differential Inflammatory Responses and Dendritic Cell Maturation.
Journal: Journal of Crohn's & colitis
Published: December 05, 2019
How do immune and mesenchymal cells influence the intestinal epithelial cell compartment in inflammatory bowel disease? Let's crosstalk about it!
Journal: Journal of leukocyte biology
Published: November 01, 2019
Last Updated: 09/26/2026